−240KRW
−17.24 BKRW
3.71 BKRW
20.55 M
About KOLON TISSUEGENE
Sector
Industry
CEO
Moon-Jong Noh
Website
Headquarters
Rockville
Employees (FY)
48
Founded
1999
ISIN
KR8840120008
FIGI
BBG00HNRMTN4
Kolon TissueGene, Inc. is a biopharmaceutical company, which engages in the development of clinical-stage cell therapies for osteoarthritis. It offers TG-C, a platform technology that consists of a combination of allogeneic primary cells combined with genetically modified cells. The company was founded by Kwan H. Lee on June 9, 1999 and is headquartered in Rockville, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
